Inflammatory bowel disease (IBD) research at Mayo Clinic

April 09, 2021


Mayo Clinic gastroenterologist William A. Faubion Jr., M.D., discusses how ongoing IBD research and harnessing the power of artificial intelligence (AI) and machine learning (ML) offer tremendous applications in understanding disease patterns, predictive modeling and targeting therapeutic interventions. At Mayo Clinic, we are on the forefront of applying these technologies and developing new treatments to benefit patients with IBD.